Pierre Fabre to buy Igenica Biotherapeutics ’ assets for treating cancer patients

French private pharmaceutical group Pierre Fabre has signed a new definitive purchase agreement to acquire several assets from US biotechnology company Igenica Biotherapeutics.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news